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Abstract: Preeclampsia is one of the complications of pregnancy and is one of the most important causes of 
maternal and fetal death. This disease usually occurs after the 20th week of pregnancy. Hypertension, proteinuria and 
different degrees of end organ damage may be present in this disease. The aim of this study was to compare CRP 
levels in normal pregnancies with pregnancies involved with preeclampsia. This was a cross sectional study that was 
conducted in 2012 among pregnant women who attended Shariati Hospital of Bandar Abbas. About 200 participants 
were included in this study and were divided into three groups with a 1:1:2 ratios. Blood samples were taken from 
all the participants and the CRP level was measured by the Latex Agglutination test. Data was analyzed with SPSS 
v.21 software using t-test and descriptive statistics. The CRP level was 17.858 ± 19.7457 in patients of the severe 
group, 15.106 ± 18.2851 among the mild group and 6.576 ± 7.5491 among the control group. The differences 
between the CRP levels of the three groups were statistically significant (P < 0.001). On the other hand the 
difference of the CRP levels of the severe and mild preeclampsia group was not significant ( P-value > 0.05). Our 
results show that CRP can be known as a risk factor for preeclampsia among pregnant women. Although performing 
a systematic review is necessary for establishing it as a routine test. 
[Atighpour F, Rajaei M, Sharifi F, Rahmatian A, Zare S. Comparison of C-Reactive Protein Concentrations of 
Patients with Preeclampsia and Normal Pregnancies. Life Sci J 2013;10(11s):78-80] (ISSN:1097-8135). 
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1. Introduction 
Preeclampsia is one of pregnancy 
complications and is an important cause of fetal and 
maternal mortality and morbidity (FG and MD 1992). 
This disease usually occurs after the 20th week of 
pregnancy and presents with hypertension, 
proteinuria and different levels of ischemic damage 
(BM 2004). It may also be associated with hemolysis, 
increase in liver enzymes and decrease in platelet 
count (Y, MD et al. 2002, BM 2004).  
Clinical and biochemical evidence suggests 
that endothelial cellular activity can be the main 
cause of preeclampsia (Gifford, August et al. 2000). 
Endothelial cell dysfunction and inflammation has an 
important role in the physiopathology of 
preeclampsia (FG and MD 1992). Recent studies 
have suggested that CRP levels can be known as a 
risk factor for preeclampsia.  
Tran et al showed in their study that the 
CRP concentrations of preeclamptic women are 
about 66% higher than the control group (Wang, 
Knottnerus et al. 2002). Also, Wolf et al reported that 
women with CRP concentrations above 4. Mg per 
liter encounter 3.5 times more to preeclampsia 
(Conde-Agudelo, Villar et al. 2008). The aim of this 
study was to compare the CRP levels of healthy and 
preeclamptic women. 
 
2. Material and Methods  
This was a case control study that was 
conducted in 2012 on pregnant women with a 
gestational age between 24 and 40, who attended 
Shariati Hospital of Bandar Abbas.  
Those who experienced premature rupture 
of membrane, chorioammunitis, premature labor, 
history of diabetes, chronic hypertension, kidney 
disease, history of smoking or substance abuse were 
excluded from the study.  
Using convenience sampling, a sample size 
of 200 women was allocated into three groups of 
control, severe preeclampsia and mild preeclampsia 
with a 2:1:1 ratio. Patients with a systolic blood 
pressure of 140 mmHg or above, or diastolic blood 
pressure of 90 mmHg who were normotensive before 
the 20th gestational week along with proteinuria (300 
mg protein in 24 hour urine or protein equal or above 
1 in dipstick) were diagnosed as mild preeclampsia.  
Patients with systolic blood pressure of 160 
mmHg or above, or diastolic blood pressure of 110 
mmHg or above and had any of the following 
symptoms were considered as severe preeclampsia: 
proteinturia (2 grams in 24 hour urine or 2+ or above 
protein using dipstick), oliguria (below 500 ml in 24 
hours), visual or brain dysfunction, papillary edema, 
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pulmonary edema, cyanosis, epigastric pain, right 
upper quadrant pain, liver dysfunction, platelet below 
100.000, signs of hemolysis, or intrauterine growth 
retardation.  
The samples were taken prior to any 
treatment. On the other hand, the participants of the 
control group were selected among women with 
normal prenatal examinations.  
Five mililiters of venous blood were 
collected from each patient and the quantitative and 
qualitative amounts of c-reactive protein (CRP) was 
measured using latex agglutination test.  
Data was entered SPSS v. 21 and analyzed 
using t-test and descriptive statistics. A p-value 
below 0.05 was considered as significant.   
 
3. Results  
In this study, 200 pregnant women were 
enrolled and were randomly allocated into three 
groups of random, mild pregnancy and severe 
pregnancy group with a 2:1:1 ratio. The mean age of 
the participants of the control, mild and severe 
preeclampsia was 27.7 ± 5.598, 28.24 ± 6.766 and 
27.7 ± 6.659 years, respectively. This difference 
wasn’t statistically significant (p>0.05). 
The mean CRP levels were 17.858 ± 
19.7457 in the severe preeclampsia group, 15.106 ± 
18.2851 in the mild preeclampsia group and 6.576 ± 













Figure -1: The CRP levels of patients of the three 
groups 
 
The level of CRP among severe 
preeclampsia and mild preeclampsia compared with 
the control group was statistically different (P<0.001 
and P=0.001, respectively). 
 
4. Discussions  
This was a case control study that was 
conducted in 2012 on 200 pregnant women who 
attended Shariati Hospital of Bandar Abbas in order 
to determine the associations between serum CRP 
levels and the incidence of preeclampsia.  
The CRP level is an indicator for 
inflammatory response of the body. Usually pregnant 
women have higher levels of CRP compared to non 
pregnant women (Guven, Coskun et al. 2009). 
Inflammatory responses occur in different stages of 
pregnancy such as implantation. Also, the increase of 
the estrogen level during pregnancy can be another 
reason for inflammatory responses (García, Celedón 
et al. 2007, Cebesoy, Balat et al. 2009). 
The findings of this study showed a 
statistically significant difference  between the CRP 
levels of the control and preeclampsia group. This 
result was consistent with the results of Huang et al, 
Cebosoy et al, Goon et al and Tejoa et al. Wolf et al 
also showed that women with high levels of CRP are 
3.5 times more likely to become preeclamptic (Tjoa, 
van Vugt et al. 2003, Cebesoy, Balat et al. 2009).  
On the other hand, animal studies have also 
shown that inflammatory processes have a role in 
preeclampsia incidence. Fas et al injected pregnant 
rats with low dose endotoxin and inducted 
hypertension and proteinuria and observed an 
elevation in CRP levels.  
Since high CRP levels are indicative of 
vascular injury and vasoconstriction, we suggest that 
systemic infections have an important role in the 
incidence of preeclampsia. On the other hand, the 
severity of preeclampsia had no significant relations 
with CRP levels. This result was not consistent with 
the results of Guven et al, Cebosoy et al, and Garcia 
et al (García, Celedón et al. 2007, Cebesoy, Balat et 
al. 2009, Guven, Coskun et al. 2009). 
One of the limitations of this study was that 
blood samples were obtained only once during 
pregnancy. However, CRP levels do not change at 
the end of pregnancy. The results of this study 
showed that CRP can be known as a risk factor for 
preeclampsia incidence among pregnant women. 
However, systemic reviews have to be conducted to 
establish if routine assessment is necessary 
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